Regulatory T cell and autoimmune diseases

Japanese Journal of Clinical Immunology

Volumn 28, Issue 5, 2005, Pages 291-299

  Tanaka, Satoshi ^a   Sakaguchi, Shimon ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

25+CD4+; Autoimmune disease; Peripheral tolerance; regulatory T cell; Treatment

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASE; HUMAN; IMMUNOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 33644699914     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.28.291     Document Type: Article

References (45)

1. Sakaguchi S.: Naturally arising CD4+ regulatory cells for immunologic self-tolerance and negative control of immune responses. Arru Rev Immunol 22: 531–562, 2004.
2. Hori S., Nomura T., Sakaguchi S.: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057–1061, 2003.
3. Hsieh C. S., Liang Y., Tyznik A. J., Self S. G., Liggitt D., Rudensky A.Y.: Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21: 267–277, 2004.
4. Setoguchi R., Hori S., Takahashi T., Sakaguchi S.: IL-2 and autoimmunity: homeostatic maintenance of CD25+CD4+ regulatory T cells via IL-2 secreted by other T cells and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005.
5. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164, 1995.
6. Asano M., Toda M., Sakaguchi N., Sakaguchi S.: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184: 387–96, 1996.
7. Brunkow M. E., Jeffery E. W., Hjerrild K. A., et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphopro-liferative disorder of the scurfy mouse. Nat Genet 27: 68–73; 2001.
8. Bennett C. L., Christie J., Ramsdell F., et al.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20–21, 2001.
9. Wu A. J., Hua H., Munson S. H., McDevitt H.O.: Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A 99: 12287–12292, 2002.
10. Gregori S., Giarratana N., Smiroldo S., Adorini L.: Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171: 4040–4047, 2003.
11. Kohm A. P., Carpentier P. A., Anger H. A., Miller S.D.: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system Inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712–4716, 2002.
12. Hori S., Haury M., Coutinho A., Demengeot J.: Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci U S A 99: 8213–8218, 2002.
13. Morgan M. E., Sutmuller R. P., Witteveen H. J., et al.: CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 48: 1452–1460, 2003.
14. Monk C. R., Spachidou M., Rovis F., et al.: MRL /Mp CD4+, CD25- T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52: 1180–1184, 2005.
15. Lindley S., Dayan C. M., Bishop A., Roep B. O., Peakman M., Tree T.I.: Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92–99, 2005.
16. Viglietta V., Baecher-Allan C., Weiner H. L., Hafler D.A.: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971–979, 2004.
17. Putnam A. L., Vendrame F., Dotta F., Gottlieb P.A.: CD4+ CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 24: 55–62, 2005.
18. Putheti P., Pettersson A., Soderstrom M., Link H., Huang Y.M.: Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol 24: 155–161, 2004.
19. Ehrenstein M. R., Evans J. G., Singh A., et al.: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200: 277–285, 2004.
20. van Amelsfort J. M., Jacobs K. M., Bijlsma J. W., Lafeber F. P., Taams L.S.: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50: 2775–2785, 2004.
21. Crispin J. C., Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoim-mun 21: 273–276, 2003.
22. Gottenberg J. E., Lavie F., Abbed K., et al.: CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J Autoimmun 24: 235–242, 2005.
23. Sugiyama H., Gyulai R., Toichi E., et al.: Dysfunctional blood and target tissue CD4+ CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174: 164–173,2005.
24. Luther C., Poeschel S., Varga M., Melms A., Tolosa E.: Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. J Neuroimmunol 164: 124–128, 2005.
25. Furuno K., Yuge T., Kusuhara K., et al.: CD25+ CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 145: 385–390, 2004.
26. Kriegel M. A., Lohmann T., Gabler C., Blank N., Kalden J. R., Lorenz H.M.: Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199: 1285–1291, 2004.
27. Longhi M. S., Ma Y., Bogdanos D. P., Cheeseman P., Mieli-Vergani G., Vergani D.: Impairment of CD4(+) CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31–37, 2004.
28. Balandina A., Lecart S., Dartevelle P., Saoudi A., Berrih-Aknin S.: Functional defect of regulatory CD4(+) CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105: 735–741, 2005.
29. Marinaki S., Neumann I., Kalsch A. I., et al.: Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 140: 181–191, 2005.
30. Seo S. J., Fields M. L., Buckler J. L., et al.: The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16: 535–546, 2002.
31. La Cava A., Ebling F. M., Hahn B.H.: Ig-reactive CD4+ CD25+ T cells from tolerized (New Zealand Black × New Zealand White) F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173: 3542–3548, 2004.
32. Pasare C., Medzhitov R.: Toll pathway-dependent blockade of CD4 +CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033–1036, 2003.
33. Mottet C., Uhlig H. H., Powrie F.: Cutting edge: cure of colitis by CD4+ CD25+ regulatory T cells. J Immunol 170: 3939–3943, 2003.
34. Mekala D. J., Geiger T.L.: Immunotherapy of autoimmune encephalomyelitis with re-directed CD4+CD25+ T-lymphocytes. Blood 2004.
35. Tang Q., Henriksen K. J., Bi M., et al.: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455–1465, 2004.
36. Morgan M. E., Flierman R., van Duivenvoorde L. M., et al.: effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52: 2212–2221,2005.
37. Bardos T., Czipri M., Vermes C., Finnegan A., Mikecz K., Zhang J.: CD4+ CD25+ im-munoregulatory T cells may not be involved in controlling autoimmune arthritis. Arthritis Res Ther 5:R106-R113,2003.
38. Baan C. C., van der Mast B. J., Klepper M., et al.: Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 80: 110–117, 2005.
39. Battaglia M., Stabilini A., Roncarolo M.G.: Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 105: 4743–4748, 2005.
40. Hadaya K., Kared H., Masson A., Chatenoud L., Zavala F.: G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J Autoimmun 24: 125–134, 2005.
41. Goudy K. S., Burkhardt B. R., Wasserfall C., et al.: Systemic overexpression of IL-10 induces CD4+ CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol 171:2270–2278,2003.
42. Luo X., Yang H., Kim I. S., et al.: Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 79: 1091–1096, 2005.
43. Taylor P. A., Lees C. J., Blazar B.R.: The infusion of ex vivo activated and expanded CD4(+) CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493–3499, 2002.
44. Chen W., Jin W., Hardegen N., et al.: Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF- beta induction of transcription factor Foxp3. J Exp Med 198: 1875–1886, 2003.
45. Zheng S. G., Gray J. D., Ohtsuka K., Yamagiwa S., Horwitz D.A.: Generation ex vivo of TGF- beta-producing regulatory T cells from CD4+ CD25- precursors. J Immunol 169: 4183–4189, 2002.